The second working group meeting of American and Chinese medicine intellectual property experts was held successfully

Source: the meeting place of 2011 / 9 / 14 working group of China pharmaceutical promotion association on September 14, 2011, China pharmaceutical promotion association and American pharmaceutical R & D and Manufacturers Association (hereinafter referred to as American Pharma) held "the second working group meeting of us China pharmaceutical intellectual property experts" in Washington, D.C The meeting was chaired by Paul neureiter, senior director of Pfizer's international trade policy department, and song Ruilin, executive chairman of China pharmaceutical promotion association The participants include: Chen Xin, deputy director of patent and Trademark Office of China Council for the promotion of international trade, sun Lifang, director of Intellectual Property Department of LVYE pharmaceutical, Chen Changxiong, Jia Hui and Huang Yi of China Council for the promotion of international trade American participants include Anthony Cino, assistant vice president for Asia Pacific Affairs of PhRMA, David E Korn, senior consultant, David Korn, senior assistant general counsel, Richard kjeldgaard, assistant vice president, Jennifer Osika of the American Chamber of Commerce, Catherine Robinson of Amgen and Michael Swanson of Sanofi The meeting of the working group consists of two parts: morning and afternoon In the morning, China and the United States each made two special reports David E Korn introduced the revision of the US patent law The amendment to the US patent law has been discussed and approved by Congress and submitted to the president for signature The main contents of the amendment are concentrated in three aspects: first, optimize the examination process of the patent office to improve the quality of the patent; second, improve the examination procedure after the grant of the patent; third, improve the patent related litigation system, and increase the penalties and judicial procedures for the illegal acts of false identification patent Richard kjeldgaard presented a report on the role of data protection systems in promoting innovation He pointed out that due to the high risk and large investment, the data protection system is of great significance to biomedicine Chen Xin and Chen Changxiong respectively made the report on the requirements for full disclosure of pharmaceutical patents in China's patent practice and the report on the development of China's pharmaceutical industry and the improvement of China's pharmaceutical patent legal system Chen Xin elaborated the requirements of patent law and patent examination guide on how to fully disclose relevant technologies in the process of drug patent application Chen Changxiong introduced the development of China's pharmaceutical industry in the past five years and the policy research on how to deal with the relationship between drug patent protection and drug registration and approval In the afternoon, China and the United States discussed the following three topics: first, how to improve the joint statement on the protection of pharmaceutical intellectual property rights to be signed by the two associations at the October Summit China Council for the promotion of drugs put forward 10 suggestions including the meaning of biomedicine The US side agreed Second, how can China Council for the promotion of drugs and the United States Pharma further strengthen cooperation In the next step, bilateral cooperation should be more pragmatic in order to achieve results The China Council for the promotion of drugs put forward five suggestions, including joint research and exhibition of innovative drugs The US side fully agrees Third, preparations for the summit in October The two sides first discussed the schedule in detail, and then discussed the related meeting affairs arrangement in depth Through the joint efforts of China and the United States, the expert working group meeting has achieved rich results and positive results, achieved the expected purpose, and laid a solid foundation for the successful holding of the October Summit and future cooperation between the two associations.